¹Ù·Î°¡±â ¸Þ´º

¹Ù·Î°¡±â ¸Þ´º º»¹®³»¿ë ¹Ù·Î°¡±â ¸ÞÀθ޴º ¹Ù·Î°¡±â

ÁÖ¿ä¾È³»

HOME »çÀÌÆ®¸Ê

FONT SIZE

ÆùƮũ±â Å°¿ò 100% 110% 120% 130% 140% ÆùƮũ±â ÁÙÀÓ
¸Þ´ºº¸±â
 
Á¦¸ñ
2/27 ¹ßÇ¥³í¹®ÀÔ´Ï´Ù.
ÀÛ¼ºÀÏ
2021-02-25
Á¶È¸¼ö
303


¾È³çÇϼ¼¿ä, À̹øÁÖ ¹ßÇ¥ÀÚ ±è¼öÁöÀÔ´Ï´Ù.

Á¦°¡ ¼±Á¤ÇÑ ³í¹®Àº 2018³â PNAS ¿¡ ÃâÆÇ µÈ
"Comparative immunogenicity and efficacy of equivalent outer membrane vesicle and glycoconjugate vaccines against nontyphoidal Salmonella" ÀÔ´Ï´Ù.

±âÁ¸ iNTS¹é½ÅÀ¸·Î ÁÖ·Î »ç¿ëµÇ´Â O-antigen glycoconjugates ¿Í »ì¸ð³Ú¶ó¿¡¼­ tolR ¸¦ deletion ÇÏ¿© ¸¸µç generalized modules for membrane antigens (GMMA) ¶ó´Â »õ·Î¿î ¹é½ÅÀ» ºñ±³ÇÑ ³í¹®À¸·Î, °¢°¢ÀÇ O antigen ÀÇ ±¸Á¶Àû Ư¡ÀÌ À¯»çÇÔÀ» ¹àÇûÀ¸¸ç immunization ÈÄ¿¡µµ GMMA ¿¡ ÀÇÇÑ anti-O-antigen IgG ¿Í serum bactericidal activity °¡ glycoconjugate ¿Í À¯»çÇϰųª ´õ ³ôÀº °ÍÀ» º¸¿©ÁÖ¾ú½À´Ï´Ù. challenge ÀÌÈÄ¿¡ bacterial burden ¶ÇÇÑ GMMA ¿¡¼­µµ ³·°Ô ³ªÅ¸³µ½À´Ï´Ù.

salmonella conjugate vaccine ½ÇÇè µðÀÚÀÎÀ» Âü°íÇÏ°íÀÚ ¼±Á¤ÇÏ¿´½À´Ï´Ù.

Åä¿äÀÏ¿¡ ºË°Ú½À´Ï´Ù.
°¨»çÇÕ´Ï´Ù.


¹ßÇ¥³í¹® ¸µÅ©: https://www.pnas.org/content/115/41/10428.long
÷ºÎÆÄÀÏ:
÷ºÎÆÄÀÏÀÌ ¾ø½À´Ï´Ù.
´ÙÀ½±Û
2/27 ¹ßÇ¥³í¹® ÀÔ´Ï´Ù
/ °ü¸®ÀÚ
¾È³çÇϼ¼¿ä. À̹øÁÖ¿¡ Á¦°¡ ¹ßÇ¥ÇÒ ³í¹®Àº Mucosal immunology¿¡ 2020³â¿¡ ÃâÆÇµÈ 'Niche rather than origin dysregulates mucosal Langerhans cells development in aged mice' ÀÔ´Ï´Ù. º» ³í¹®¿¡¼­´Â epidermis¿¡ ºñÇÏ¿© ´ú ¾Ë·ÁÁø oral mucosa Langerhens cell¿¡ ´ëÇÏ¿© ¿¬±¸¸¦ ÇÏ¿´À¸¸ç ³ëÈ­¿¡ µû¸¥..
ÀÌÀü±Û
2/20 ¹ßÇ¥³í¹® ÀÔ´Ï´Ù
/ °ü¸®ÀÚ
¾È³çÇϼ¼¿ä, ¹ÎÁ¤ÀÔ´Ï´Ù Á¦°¡ ³»ÀÏ ¹ßÇ¥ÇÒ ³í¹®ÀºCell reports¿¡ ¿ÃÇØ °ÔÀçµÈ ³í¹®À¸·Î, ±âÁ¸¿¡ mouse thymus ³»¿¡¼­ TCR signal¿¡ ÀÇÇØ gd T cellÀÇ effector fate°¡ °áÁ¤µÇ¾îÁø´Ù°í ¾Ë·ÁÁøµ¥ ÀÖ¾î TCR signalingÀÌ Á¶ÀýÇÏ´Â E-protein°ú TCF-1À̶ó´Â Àü»çÀÎÀÚ¸¦ ÅëÇØ gd T cell lineage¿Í effector fate..